Royalty Pharma reports second quarter 2026 results

Go back to Royalty Pharma reports second quarter 2026 results
REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 57.64 +0.87 (1.53%)
Previous Close $56.77    52 Week High $3.48 
Open $57.43    52 Week Low $0.80 
Day High $57.83    P/E N/A 
Day Low $56.53    EPS $-1.54 
Volume 1,411,004